NYU Langone and NYU Grossman in the News
Yankees’ Aaron Judge banking on experimental medical therapy: ‘My first time doing this’ | Klapisch
NJ.com
New York Yankees player Aaron Judge is using an experimental therapy called platelet-poor plasma (PPP) injections to recover from a calf injury. Providing expert commentary, Spencer Stein, MD, sports orthopedic surgeon at NYU Langone Health, notes that while preliminary studies show players returning earlier from muscle injuries, PPP is still considered promising as large studies are not yet available. Dr. Stein also discussed the risks of returning to play, including the 'eccentric load' on a muscle when it lengthens while contracting, and the potential for such injuries following an extended layoff.
Also reporting was: Yahoo Sports
9/29/2026
Why are people stomping on salt before bed?
Women's Health
A viral TikTok trend known as 'salt stomping' is being promoted as a way to ease anxiety and improve sleep, but medical experts say there is no scientific evidence to support these claims. Thea Gallagher, PsyD, clinical associate professor of psychaitry at NYU Langone Health, suggests that any calming effect likely comes from the ritual of focusing on one's senses rather than the salt itself. She recommends more reliable methods like progressive muscle relaxation. An expert from Icahn School of Medicine at Mount Sinai also warns that the practice can lead to skin irritation and infection.
Also reporting was: Yahoo Health, MSN Mexico
9/29/2026
Men's Journal
In an article for World Heart Day, cardiologists shared tips for men to naturally lower blood pressure. Nieca Goldberg, MD, cardiologist at NYU Langone Health and clinical associate professor of medicine at NYU Grossman School of Medicine, advises choosing an aerobic exercise you will continue doing, noting that walking is a simple way to start. Other recommendations include strength training, modest weight loss, limiting alcohol consumption, reducing sodium intake, increasing potassium, and ensuring adequate sleep. The piece highlights that nearly half of US adults have hypertension, a significant risk factor for cardiovascular disease.
Also reporting was: Yahoo Health
9/29/2026
Glaucoma symposium features competition for the survivor of ‘Temporal Island’
EyeWorld
A 'Survivor'-themed glaucoma symposium at the 2026 ASCRS Annual Meeting featured several ophthalmologists competing for audience votes. Ariana Levin, MD, assistant professor in the Department of Ophthalmology at NYU Grossman School of Medicine and associate program director for the Glaucoma Fellowship Program at NYU Langone Health, presented on the use of lasers for uveitic glaucoma. She advised collaborating with uveitis specialists and controlling inflammation before and after the procedure. The session also covered selective laser trabeculoplasty (SLT) and MIGS. Dr. Levin was voted off after the first round of presentations.
9/29/2026
GLP-1 users are losing hair, but research says the real reason is more complex than expected
Yahoo Health
Reports of hair loss are increasing among users of GLP-1 medications, a side effect documented in clinical trials. The primary cause is often telogen effluvium, the body's stress reaction to rapid weight loss. A study from NYU Grossman School of Medicine also revealed a genetic component, finding that increased GLP-1 receptor activity is linked to a higher risk of male pattern baldness. Senior investigator Lynn Petukhova, PhD, assistant professor in the Ronald O. Perelman Department of Dermatology and Department of Population Health at NYU Grossman School of Medicine, noted this as the first direct genetic link.
9/29/2026
Medical Daily
A trial published in JAMA Neurology found hearing aids did not significantly reduce two-year dementia rates in adults with mild cognitive impairment. While the larger US-based ACHIEVE trial reached a similar conclusion, a subsequent analysis of that study led by NYU Langone Health found participants treated for hearing loss maintained about one more social connection on average over three years than those in a control group. The article also discusses the benefits of hearing aids for quality of life, cost considerations, and FDA regulations allowing for over-the-counter devices, which are not covered by Original Medicare.
9/29/2026
Aclarion announces NYU Langone Health as new clinical site for CLARITY trial
Markets Insider
Aclarion has announced that NYU Langone Health will serve as a new clinical site for its CLARITY trial. The study is designed to demonstrate the clinical and economic value of Nociscan technology in spine surgery.
9/29/2026
